3-dimethylaminopropylamine has been researched along with Pancreatic Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, PW; Luo, S; Tian, BL; Wang, L; Xiao, LY; Zeng, YC; Zhang, ZR | 1 |
1 other study(ies) available for 3-dimethylaminopropylamine and Pancreatic Neoplasms
| Article | Year |
|---|---|
A novel gemcitabine derivative-loaded liposome with great pancreas-targeting ability.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Deoxycytidine; Diamines; Drug Carriers; Drug Delivery Systems; Gemcitabine; Liposomes; Mice, Inbred C57BL; Pancreas; Pancreatic Neoplasms; Phosphatidylethanolamines; Polyethylene Glycols | 2019 |